Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass

IF 1.1 Q4 ONCOLOGY Kidney Cancer Pub Date : 2019-01-01 DOI:10.3233/kca-190066
A. May, Anirudh Guduru, J.P. Fernelius, S. Raza, F. Davaro, S. Siddiqui, Z. Hamilton
{"title":"Current Trends in Partial Nephrectomy After Guideline Release: Health Disparity for Small Renal Mass","authors":"A. May, Anirudh Guduru, J.P. Fernelius, S. Raza, F. Davaro, S. Siddiqui, Z. Hamilton","doi":"10.3233/kca-190066","DOIUrl":null,"url":null,"abstract":"Background: Renal masses can be surgically treated by partial nephrectomy (PN) or radical nephrectomy (RN); however, in 2009 guidelines recommended PN as the standard of care for cT1a renal masses. Objective: To evaluate national trends of surgically appropriate patients using the National Cancer Database (NCDB) for utilization of PN focusing on guideline release, evaluating underlying health disparity. Methods: We identified 99,035 patients from 2004–2015 that underwent surgical resection of cT1a renal masses. We evaluated treatment proportions over time of patients treated with PN or RN. Logistic regression was utilized for multivariable analysis. Results: PN increased from 40.2% in 2004 to 71.3% in 2015 (p < 0.001). Older patients were more likely to be treated with RN (OR 1.018, p < 0.001), as were those with Charlson score 2 or 3+ (OR 1.288 and 2.074, p < 0.001). Patients with lower income were more likely to be treated with RN (OR 1.186, p < 0.001) as were uninsured patients (OR 1.108, p = 0.018) and low volume centers (OR 1.063, p < 0.001). Females were more likely to undergo RN (OR 1.123, p < 0.001) as were black patients (OR 1.339, p < 0.001). While these demographic trends persisted after the release of the guidelines, all associations decreased except for Charlson score and race. Black patients became more likely to undergo RN (pre-guideline OR 1.248 vs post-guideline OR 1.474, p < 0.001). Patients treated with RN had worsened mortality (17.4% vs. 7.3%, p < 0.001). Conclusions: Although use of PN in surgically appropriate patients for cT1a renal masses has increased over time, 30% of patients underwent RN in 2015. Socioeconomic disparities affect treatment decisions and require additional research.","PeriodicalId":17823,"journal":{"name":"Kidney Cancer","volume":"1 1","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3233/kca-190066","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3233/kca-190066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 9

Abstract

Background: Renal masses can be surgically treated by partial nephrectomy (PN) or radical nephrectomy (RN); however, in 2009 guidelines recommended PN as the standard of care for cT1a renal masses. Objective: To evaluate national trends of surgically appropriate patients using the National Cancer Database (NCDB) for utilization of PN focusing on guideline release, evaluating underlying health disparity. Methods: We identified 99,035 patients from 2004–2015 that underwent surgical resection of cT1a renal masses. We evaluated treatment proportions over time of patients treated with PN or RN. Logistic regression was utilized for multivariable analysis. Results: PN increased from 40.2% in 2004 to 71.3% in 2015 (p < 0.001). Older patients were more likely to be treated with RN (OR 1.018, p < 0.001), as were those with Charlson score 2 or 3+ (OR 1.288 and 2.074, p < 0.001). Patients with lower income were more likely to be treated with RN (OR 1.186, p < 0.001) as were uninsured patients (OR 1.108, p = 0.018) and low volume centers (OR 1.063, p < 0.001). Females were more likely to undergo RN (OR 1.123, p < 0.001) as were black patients (OR 1.339, p < 0.001). While these demographic trends persisted after the release of the guidelines, all associations decreased except for Charlson score and race. Black patients became more likely to undergo RN (pre-guideline OR 1.248 vs post-guideline OR 1.474, p < 0.001). Patients treated with RN had worsened mortality (17.4% vs. 7.3%, p < 0.001). Conclusions: Although use of PN in surgically appropriate patients for cT1a renal masses has increased over time, 30% of patients underwent RN in 2015. Socioeconomic disparities affect treatment decisions and require additional research.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
指南发布后部分肾切除术的当前趋势:小肾肿块的健康差异
背景:肾肿块可以通过部分肾切除术(PN)或根治性肾切除术(RN)进行手术治疗;然而,在2009年的指南中推荐PN作为cT1a肾肿块的标准治疗。目的:利用国家癌症数据库(NCDB)评估全国手术适宜患者使用PN的趋势,重点关注指南发布,评估潜在的健康差异。方法:我们确定了2004-2015年间99,035例手术切除cT1a肾肿块的患者。我们评估了接受PN或RN治疗的患者随时间的治疗比例。采用Logistic回归进行多变量分析。结果:PN由2004年的40.2%上升至2015年的71.3% (p < 0.001)。老年患者更有可能接受RN治疗(OR 1.018, p < 0.001), Charlson评分为2或3+的患者也是如此(OR 1.288和2.074,p < 0.001)。收入较低的患者更有可能接受RN治疗(OR 1.186, p < 0.001),没有保险的患者(OR 1.108, p = 0.018)和低容量中心(OR 1.063, p < 0.001)。女性更容易发生RN (OR 1.123, p < 0.001),黑人患者也同样如此(OR 1.339, p < 0.001)。虽然这些人口统计趋势在指南发布后仍然存在,但除了查尔森评分和种族外,所有关联都有所下降。黑人患者更有可能接受RN(指南前OR 1.248 vs指南后OR 1.474, p < 0.001)。接受RN治疗的患者死亡率加重(17.4% vs. 7.3%, p < 0.001)。结论:尽管随着时间的推移,适合手术的cT1a肾肿块患者使用PN的情况有所增加,但2015年仍有30%的患者接受了RN。社会经济差异影响治疗决策,需要进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Kidney Cancer
Kidney Cancer Multiple-
CiteScore
0.90
自引率
8.30%
发文量
23
期刊最新文献
Emerging Antibody-Drug Conjugate Therapies and Targets for Metastatic Renal Cell Carcinoma Genomic and Transcriptomic Characteristics of Tumors of Patients with Metastatic Clear Cell Renal Cell Carcinoma Clinically Benefiting from First-Line Treatment with Ipilimumab Plus Nivolumab Nephrotoxicity Associated with Contemporary Renal Cell Carcinoma Regimens: A Systematic Review and Meta-Analysis Targeted Literature Review of Outcomes to Initial Systemic Therapy for Advanced/Metastatic Non-Clear Cell Renal Cell Carcinoma in Observational Studies Fibrinogen Levels in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: Results of a Multicenter Prospective Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1